5-FU-free chemotherapy combination as an alternative for first-line treatment of recurrent or metastatic HNSCC Presented ByDr Marcin Dzienis, Gold Coast University Hospital, Australia TrialPhase 4, KEYNOTE-B10 ConferenceESMO 2022 TypePeer-reviewed article 17 November 2022 01:06